J. Lipid Res. Acyl Labeled PIP's available August 1, 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M200293-JLR200 on September 16, 2002

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M200293-JLR200v1
43/12/2130    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meaney, S.
Right arrow Articles by Björkhem, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meaney, S.
Right arrow Articles by Björkhem, I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 43, 2130-2135, December 2002
Copyright © 2002 by Lipid Research, Inc.

On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation

: critical importance of the position of the oxygen function

Steve Meaney, Karl Bodin, Ulf Diczfalusy and Ingemar Björkhem1

Division of Clinical Chemistry, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden

Published, JLR Papers in Press, September 16, 2000. DOI 10.1194/jlr.M200293-JLR200

1 To whom correspondence should be addressed. e-mail: ingemar.bjorkhem{at}chemlab.hs.sll.se


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Oxysterols possess powerful biological activities. Some of their effects on the regulation of key enzymes are similar to those of cholesterol, but are much more potent. One of the critical properties of oxysterols is their ability to pass lipophilic membranes at a high rate. Transfer of unesterified 25-hydroxycholesterol from red blood cells to plasma has been reported to occur more than 1,000 times faster than cholesterol. Here we have measured the relative rate of such translocation of the three major oxysterols in human circulation: 27-hydroxycholesterol, 24S-hydroxycholesterol, and 4ß-hydroxycholesterol. The distance from the 3ß-hydroxyl group to the additional hydroxyl group is the greatest possible in 27-hydroxycholesterol and the least possible in 4ß-hydroxycholesterol. The rate of exchange between erythrocytes and plasma was found to be high for 27-hydroxycholesterol and 24S-hydroxycholesterol, and hardly possible to measure for 4ß-hydroxycholesterol and cholesterol. When injected intravenously into humans, deuterium labeled 24- and 27-hydroxycholesterol caused an immediate high enrichment of the corresponding plasma sterols followed by a decay. After injection of labeled 4ß-hydroxycholesterol, the maximum deuterium enrichment occurred after 2–3 h, when secretion of the oxysterol from the liver is likely to be the limiting factor. When radiolabeled cholesterol was injected under the same conditions, maximum appearance of label occurred after about 2 days.

The results illustrate the importance of the position of the additional oxygen in oxysterols and are discussed in relation to the rate of metabolism and biological effects of these oxysterols.

Abbreviations: 25-hydroxycholesterol, cholest-5-ene-3ß,25-diol; 7{alpha}-hydroxycholesterol, cholest-5-ene-3ß,7{alpha}-diol; 7ß-hydroxycholesterol, cholest-5-ene-3ß,7ß-diol; 4ß-hydroxycholesterol, cholest-5-ene-3ß,4ß-diol; 7-ketocholesterol, cholest-5-ene-7-keto-3ß-ol; 24S-hydroxycholesterol, cholest-5-ene-3ß,24S-diol; 27-hydroxycholesterol, cholesten-5-ene- 3ß,25R(26)-diol

Supplementary key words 27-hydroxycholesterol • 4ß-hydroxycholesterol • 24S-hydroxycholesterol • oxysterol flux • cholesterol flux


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Oxysterols are mono-oxygenated derivatives of cholesterol that have been implicated in many cellular processes (13). One of their most important and well-characterized roles is as intermediates or end products in cholesterol excretion pathways (1, 2, 4). Introduction of an oxygen moiety into the largely hydrophobic cholesterol designates it to a highly efficient excretion pathway with bile acids as typical end products. Oxysterols are considerably more potent than cholesterol in modulating lipid homeostasis, at least under in vitro conditions. This has lead to widespread endorsement of the homeostatic relevance of oxysterols, despite their extremely low concentrations in most physiological situations.

The rapid catabolism of oxysterols is a function of several different properties, including their ability to enter cholesterol excretion pathways at a variety of stages and their biophysical attributes vis á vis translocation between different lipophilic compartments.

The spontaneous transfer of cholesterol between different lipophilic compartments (e.g., from erythrocytes to lipoproteins) is well recognized, and several studies have investigated the kinetic parameters of this process. Lange et al. (5) characterized the transfer of cholesterol between erythrocytes and plasma, finding that it progressed in an apparently first order fashion except for an initial rapid component of ~15% when using erythrocytes as cholesterol donors. The first-order rate constant for cholesterol release from red cells to a variety of lipophilic acceptors was estimated to be ~1 x 10-4 s-1, with a t1/2 of ~2 h. In similar experiments the transfer of 25-hydroxycholesterol from erythrocytes to plasma was found to occur about 2,000 times faster than that of cholesterol, though it was not possible to estimate the kinetics of this exchange (6).

More recently, the transfer of different cholesterol hydroperoxides between erythrocyte ghosts and unilamellar liposomes was investigated (7). Under the conditions used in these studies, the rate constant for the transfer of cholesterol hydroperoxides was estimated to be about 65 times that of cholesterol (Ka ~3.27 x 10-4 min-1 and Ka ~2.44 x 10-2 min-1 for cholesterol and cholesterol hydroperoxides, respectively).

Using a phospholipid monolayer system Theunissen et al. (8) investigated different membrane properties of the cholesterol auto-oxidation products 7-ketocholesterol, 7{alpha}-hydroxycholesterol, 7ß-hydroxycholesterol, and 25-hydroxycholesterol. In this study, position dependent effects of the hydroxyl or keto group on the membrane properties (e.g., interfacial orientation, membrane surface area, and membrane condensation) of the oxysterols were observed, with a clear division between the properties of oxysterols hydroxylated in the side chain or the nucleus. In particular, the rate of transfer of radiolabeled oxysterols from a monolayer to acceptor particles (lipoproteins or liposomes) followed a clear rank order with the highest rate of transfer observed for 25-hydroxycholesterol and the lowest for 7-ketocholesterol. Under the conditions used, there was a 20-fold difference between the rates of translocation of these oxysterols, while that of cholesterol was hardly measurable.

Quantitatively, the most important oxysterols in human circulation are 24S-, 27-, and 4ß-hydroxycholesterol (1). 24S-Hydroxycholesterol is predominantly formed in the brain and, as judged by animal experiments, is able to traverse the blood-brain barrier several orders of magnitude more efficiently than cholesterol. Conversely, 27-hydroxycholesterol is formed in many tissues and, based on experiments in cell culture systems, is able to rapidly cross the plasma membrane and enter the extracellular space. The ability to translocate between different physiological compartments, in addition to their obligate hepatic metabolism, permits these oxysterols to act as unidirectional transport forms of cholesterol.

The in vivo origin of 4ß-hydroxycholesterol has recently been elucidated (9). This oxysterol is formed by the cytochrome P450 CYP3A4, and changes in the expression of this enzyme may have consequences for the plasma levels of 4ß-hydroxycholesterol.

24S- and 4ß-hydroxycholesterol have both been reported to be efficacious activators of the liver X receptors LXR-{alpha} (NR1H3) and -ß (NR1H2), nuclear receptors believed to be important regulators of genes involved in cholesterol and lipid homeostasis (10, 11). Data on 27-hydroxycholesterol is less consistent, with one group reporting efficient activation (12) while others do not.

There are few studies detailing the properties of the quantitatively dominating oxysterols, with most studies using readily available oxysterols (often auto-oxidation products). In the present study, we investigate the relationship between the position of an oxysterol's hydroxyl group and its effect on the kinetics of the steroid when administered to human volunteers. Dramatic position dependent effects were observed on both the rate of transport of oxysterols between lipophilic compartments and the in vivo kinetics of deuterium labeled oxysterols.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Materials
Tritium labeled cholesterol and 25-hydroxycholesterol were purchased from Perkin-Elmer, Life Sciences. Before the flux experiments they were diluted with the corresponding unlabeled compound to give a specific radioactivity of 3 x 106 cpm/µg and 0.12 x 106 cpm/µg, respectively.

In the in vivo experiment with [3H]cholesterol, the material had a specific radioactivity of 0.02 x 106 cpm/µg. 7{alpha}-3H-labeled 7ß-hydroxycholesterol and 7ß-3H-labeled 7{alpha}-hydroxycholesterol were synthesized by reduction of 7-ketocholesterol with tritium labeled sodium borotritide as described previously (13), and had a specific radioactivity of 0.1 x 106 cpm/µg and 0.5 x 106 cpm/µg, respectively. 3H-labeled 4ß-hydroxycholesterol, 24-hydroxycholesterol, and 27-hydroxycholesterol were synthesized as described previously (1416) and had specific radioactivities of 0.08 x 106 cpm/µg, 0.4 x 106 cpm/µg, and 0.3 x 106 cpm/µg, respectively. 2H-labeled 4ß-hydroxycholesterol, 24-hydroxycholesterol, and 27-hydroxycholesterol were synthesized as described previously (17, 18).

Human serum albumin, 200 mg/ml, was obtained from Amersham Biosciences (Uppsala, Sweden). All solvents and buffer salts were of analytical grade.

Preparation of labeled erythrocytes
The flux of oxysterols between erythrocytes and plasma was estimated essentially as described (6). Briefly, packed washed erythrocytes were prepared by washing freshly drawn whole blood three times in flux buffer (150 mM NaCl, 5 mM NaPi, 5 mM glucose, pH 7.5) and carefully removing the buffy coat. One microgram of radiolabeled oxysterol was dissolved in 10 µl of ethanol and mixed with 1 ml of flux buffer and 1 ml of prepared erythrocytes. This suspension was incubated on ice for 60–90 min before the cells were washed as before. Aliquots of labeled cells (10 µl) were kept on ice until required. As judged by the absence of visible haemolysis, this treatment was not shown to affect the stability of the blood cells.

Preparation of exchange plasma
Plasma was prepared from fresh EDTA anticoagulated whole blood by centrifugation at 1,600 g for 5 min. Plasma was heat inactivated at 56°C for 50 min before being centrifuged at 15,000 g for 30 min. The clear central fraction of the plasma preparation (corresponding to about 80% of the total volume) was removed and refrigerated until required.

Oxysterol flux experiments
Ten-microliter aliquots of labeled erythrocytes were rapidly brought to 37°C. At t = 0, 90 µl of a 1:1 mixture of heat treated plasma and flux buffer, equilibrated to 37°C, was added to the pre-heated cells. At suitable intervals (typically t = 5, 10, and 30 s), the erythrocytes were pelleted at maximum speed in a chilled benchtop centrifuge. Aliquots of the supernatant were mixed with 10 ml of liquid scintillation reagent (Lumasafe, Lumac LSV, Groningen, Netherlands) and counted using a Wallac Winspectral 1414 liquid scintillation counter (Wallac LKB, Finland). To determine the sterol available for exchange, aliquots of labeled erythrocytes were lysed with deionised water and extracted with chloroform-methanol (2:1, v/v). The organic phase was dried before counting as before.

In some experiments, the direction of the flux was reversed and the labeling of the erythrocytes was followed.

In vivo experiments
Five hundred micrograms of the appropriate deuterium labeled sterols (4ß-hydroxycholesterol, 24-hydroxycholesterol, or 27-hydroxycholesterol in different experiments) and, in one experiment, tritium labeled cholesterol, was dissolved in ethanol, mixed with human serum albumin and physiological sodium chloride solution (0.9%, w/v), and administered intravenously to a healthy male volunteer 60 years of age (body mass index 25) or to a healthy female volunteer 64 years of age (body mass index 24). When the same subject participated in more than one experiment, there was an interval of at least 1 month between the experiments. At suitable time intervals blood samples were collected and the deuterium enrichment was determined by GC-MS as described in detail previously (14, 17). Determination of the tracer activity of plasma was carried out by measuring the total counts in an aliquot of plasma from each time point. No quenching effect was observed in these analyses.

It should be noted that the experiments described above with the same deuterium labeled oxysterols have been performed previously (14, 17). The goal in these previous experiments was to determine the half-life of the oxysterols and the early phase of the kinetics was therefore never followed.

GC-MS analysis
Oxysterols were analyzed as trimethylsilylether derivatives as previously described (19), except that no internal standard was added. The instrument used was a Hewlett Packard Series II gas chromatograph equipped with an HP-5MS capillary column (30m x 0.25 mm, 0.25 um phase thickness) connected to an HP 5972 mass selective detector and an HP 7673A automatic sample injector. The following ions were monitored: m/z 579 (deuterium labeled 4ß-hydroxycholesterol), m/z 573 (unlabeled 4ß-hydroxycholesterol, m/z 416 (deuterium labeled 24-hydroxycholesterol, m/z 413 (unlabeled 24-hydroxycholesterol), m/z 461 (deuterium labeled 27-hydroxycholesterol), and m/z 456 (unlabeled 27-hydroxycholesterol).

Ethical permissions
All experiments on human volunteers were approved by the local ethical committee.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Transfer of oxysterol from erythrocytes to plasma
As Fig. 1 shows, the transfer of all oxysterols tested except 4ß-hydroxycholesterol, was found to occur at a much greater rate than cholesterol. The three side-chain oxidized oxysterols were translocated at a considerably higher rate than the oxysterols with an oxygen function in the C-7 position. The rate of translocation of 4ß-hydroxycholesterol appeared to be even lower than that of cholesterol.



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 1. Transfer of cholesterol (filled diamonds), 4ß-hydroxycholesterol (open squares), 7ß-hydroxycholesterol (open triangles), 7{alpha}-hydroxycholesterol (filled triangles), 24S-hydroxycholesterol (filled circles), 25-hydroxycholesterol (open circles), and 27-hydroxycholesterol (open diamonds) from 3H-sterol labeled erythroctes to plasma. The difference between nuclear and side chain oxidized sterols is readily apparent. The inset shows the transfer of cholesterol over an extended time course.

 
It should be emphasized that the time-course for the transfer during the first 5 s of the experiment was not possible to evaluate. During this period of time, there is a very rapid initial burst of sterol transfer. In previous work, this initial burst of cholesterol transfer has been subtracted in the calculations of the relative rates of transfer (5, 7). This background has been estimated by various studies to be between 10% and 20% (5, 7, 20, 21).

In an attempt to reduce the problems with the initial burst of transfer, we also studied a reverse transfer in the same system. In this case, we loaded the heat-inactivated plasma with the labeled sterol and measured the rate of labeling appearance of the label in erythrocytes. With this technique it was possible to reduce the initial burst of transfer of labeled cholesterol from about 10% down to 1%. The rank order between the different oxysterols did not change by this technique (results not shown).

Due to the obvious limitations of the present, as well as previous, attempts to measure rate of translocation of oxysterols, no exact figure can be given. A clear rank order can be defined, however. After the initial burst during the first 5 s of the experiment, the transfer of all side chain hydroxylated species tested occurred at a rate 30–50-fold greater than cholesterol, while transfer of the 7-oxygenated species was only about 5-fold greater than cholesterol. Using this method the transfer of cholesterol in some experiments was monitored over an extended time course. A plateau of cholesterol transfer was observed at 60 s with an apparent second phase beginning at this point (inset, Fig. 1).

Using a technique essentially identical to that previously described (5), oxysterol transfer over a time course up to 3 h was also monitored (results not shown). While a similar rank order of sterol transfer was found, the relatively large initial burst of sterol transfer precluded the use of this technique in the investigation of the physiologically dominating oxysterols; however, the similarity of the transfer of cholesterol and 4ß-hydroxycholesterol was also readily apparent with this technique.

In vivo kinetics of oxysterols
To further elucidate the consequences of different rates of translocation, deuterium labeled analogues of 4ß-hydroxycholesterol, 24-hydroxycholesterol, and 27-hydroxycholesterol were injected as a bolus dose to healthy volunteers (at least one experiment with each oxysterols in each of the two volunteers). The elimination of deuterium labeled 27-hydroxycholesterol was so fast that deuterium enrichment of plasma 27-hydroxycholesterol was only detectable in the first sample collected. This is in accord with the previous result that the half-life of 27-hydroxycholesterol in plasma is extremely short, at least less than 0.75 h (22). No further attempts were therefore made to study the kinetics of 27-hydroxycholesterol with this technique.

The kinetics of representative experiments with deuterium labeled 24-hydroxycholesterol and 4ß-hydroxycholesterol are shown in Fig. 2 . Maximal labeling of circulating 24-hydroxycholesterol occurred within 2 min after the injection while the maximal labeling of 4ß-hydroxycholesterol occurred after about 5 h. Subsequently, approximate first order kinetics were followed by both compounds with an estimated terminal half-life of ~10 h for 24S-hydroxycholesterol (17) and ~60 h for 4ß-hydroxycholesterol (Fig. 3) (14). For reasons of comparison, 3H-labeled cholesterol was injected in one of the volunteers under the same conditions as the above oxysterols. The time course of the plasma label is shown in the inset of Fig. 2. After an initial rapid decrease a slow increase in plasma label occurred with the tracer peak occurring after about 2 days. In accordance with previous work, elimination by first order of kinetics occurred after 2–3 days.



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2. Deuterium enrichment of circulating 4ß-hydroxycholesterol (open squares) and 24S-hydroxycholesterol (filled circles) after injection of a bolus dose of deuterated sterols in a healthy volunteer. A clear secretion phase prior to an elimination phase is obvious with 4ß-hydroxycholesterol, while only the secretion and elimination phases are visible for 24S-hydroxycholesterol. The inset shows the change in the activity of plasma after administration of 3H-cholesterol (filled diamonds). As expected the redistribution, secretion, and elimination phases are clearly defined.

 


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 3. Terminal elimination kinetics of injected 3H-cholesterol (filled diamonds), deuterium labeled 4ß-hydroxycholesterol (open squares), and 24S-hydroxycholesterol (filled circles). The elimination of 4ß-hydroxycholesterol is between that of 24-hydroxycholesterol and cholesterol, highlighting the "cholesterol-like" character of this oxysterol.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Erythrocytes were used as a model sterol donor system for several reasons: they lack the capacity to metabolize cholesterol, are well characterized with respect to cholesterol transfer, and are readily available in a highly purified form. In previous investigations the transfer of sterols between lipophilic compartments was quenched at suitable time points by the dilution of the transfer mixture with a large excess of cold buffer followed by separation via centrifugation (5, 7, 21); however, due to the rapidity of oxysterol transfer this method was found to be unsuitable for the current studies. The early phase of the oxysterol transfer is missed, in particular in the case of the side chain oxidized sterols (unpublished observations). The rapid centrifugal separation of cells and plasma used here allowed a better evaluation of the transfer during the early phase. Despite this, the very rapid burst of transfer during the first few seconds of the experiment prevented a more precise definition of the kinetic parameters.

While there are few studies directly investigating the properties of oxysterols within lipid bilayers, cholesterol has been the subject of sustained investigation. The results of these studies are instructive in the generation of models for the behavior of oxysterols observed in the current study. When cholesterol is incorporated into a lipid bilayer its preferential orientation is such that the 3-hydroxyl group interacts with the nearby polar headgroup, with the rest of the cholesterol molecule oriented roughly perpendicular to the plane of the membrane (23) (Fig. 4) . This configuration permits the maximum interactions between both the non-polar regions of the cholesterol molecule and the acyl chains of the bilayer lipids to occur, while minimizing the exposure of the hydroxyl group to a non-polar environment.



View larger version (30K):
[in this window]
[in a new window]
 
Fig. 4. Model for the orientation of oxysterols in membrane bilayers. The introduction of an hydroxyl group into the side chain leads to local reordering of the membrane phospholipids. The acyl chains are distorted by the hydrophilic hydroxyl group, and the polar phospholipid headgroups are deformed in order to maintain the membrane integrity. The net result of these changes is that it is easier for a side chain oxidized sterol to desorb from the membrane.

 
In the case of oxysterols, the introduction of an additional polar moiety into the hydrophobic region should lead to a redistribution of the sterol in conjunction with a local reordering of the acyl chains. This is supported by molecular dynamics simulations that show that the C-6 keto group of 6-ketocholestanol leads to the movement of this sterol towards the polar headgroup, with the net effect of increasing both the membrane area and the acyl chain disorder (24). As judged by pressure-area isotherms of mixtures of a phospholipid and side-chain oxidized cholesterol species, the presence of the oxysterol expanded the area of phospholipid monolayers at low molecular ratios (25). Increasing the area of the membrane is likely to facilitate desorption of an oxysterol from it. Based on biophysical studies, it has been suggested that there may be a perpendicular shuttling of 25-hydroxycholesterol between the inner and outer monolayer of the membrane, causing a local disordering of the lipids and a higher permeability of the membrane (8) (Fig. 4). Such an effect would also facilitate a desorption from the membrane and explain the high rate of translocation of side-chain oxidized sterols across biological membranes. According to this hypothesis the highest rate of transport of a side-chain oxidized oxysterol should be expected for an oxysterol in which the distance between the 3ß- and the side chain hydroxyl group is the greatest possible, i.e., 27-hydroxycholesterol. As shown in Fig. 1, the rate of transfer of 25- and 27-hydroxycholesterol from erythrocytes to plasma lipids was found to be higher than that of any other of the oxysterols tested.

A consequence of the above hypothesis is that hydroxyl groups in the nucleus should have less disturbing effects on membrane lipids, and thus less effect on permeability. 7ß-Hydroxycholesterol has been reported to be redistributed between a monomolecular layer and lipoproteins at a rate considerably slower than that of 25-hydroxycholesterol (8). As shown in Fig. 1, this was confirmed in our study. The rate of transport of tritium-labeled 7ß-hydroxycholesterol was found to be considerably lower than the rate of transport of the three side-chain oxidized oxysterols, but greater than the rate of transport of labeled cholesterol. 4ß-Hydroxycholesterol should be the most cholesterol-like oxysterol, and in accordance with this, the rate of translocation of 4ß-hydroxycholesterol was similar to that of cholesterol in the system used.

The marked difference in the rate of translocation of 24S-hydroxycholesterol and 4ß-hydroxycholesterol observed in our in vitro system is likely to be of importance for the in vivo kinetics of these oxysterols. In addition to the capacity of the systems able to metabolize the oxysterol, the rate of translocation between different compartments may be a critical factor. When cholesterol is introduced into the circulation by intravenous injection of a bolus dose, there is a rapid uptake in the liver and to some extent also in some other organs or tissues. This phase is followed by incorporation of the sterol into lipoproteins and subsequent secretion. The secretion phase is followed by a distribution phase during which cholesterol equilibrates with the exchangeable pools. In parallel with this, there is a slow elimination of cholesterol in the form of bile acids or unchanged cholesterol in bile. These different phases are well illustrated by the results of the present experiment with labeled cholesterol (inset, Fig. 2).

The fate of an administered oxysterol would be expected to be similar to that of cholesterol. In agreement with this, the distribution of oxysterols in lipoproteins is similar to that of cholesterol (9, 26). Due to the rapid translocation of a side-chain oxidized oxysterol, some of the steps may however occur too rapidly to be clearly defined. Alternatively, the efficiency of later stages may obscure one or more of the earlier steps. Among the different oxysterols administered, only 4ß-hydroxycholesterol showed "cholesterol-like" kinetics with a clear secretion phase occurring prior to the elimination phase (Fig. 2). In the case of 24- and 27-hydroxycholesterol, no secretion phase could be defined, while with 24-hydroxycholesterol both an equilibration phase and an elimination phase were observed. Only part of the elimination could be followed in the case of 27-hydroxycholesterol.

The capacity of the systems involved in metabolism of the different oxysterols is likely to be the most critical factor for the elimination kinetics. The rate of translocation of the oxysterols across biological membranes must however also be of importance, and for some, oxysterols (e.g., 4ß-hydroxycholesterol) this rate is likely to be a limiting factor for part of the process (e.g., the secretion phase).

There is a striking relation between the rate of translocation of steroids in biological membranes and the rate of their elimination. Side-chain oxidized oxysterols are cytotoxic and are very potent suppressors of cholesterol synthesis (13). For example, 25-hydroxycholesterol is a far more potent suppressor of cholesterol synthesis in cultured cells than 4ß-hydroxycholesterol (27). The observed properties of side-chain oxidized oxysterols may well be linked to their membrane-disturbing effects. It may be speculated that evolution has favored metabolic systems that are able to minimize the risk for accumulation of the fast-moving membrane-disturbing oxysterols. Oxysterol 7{alpha}-hydroxylase (CYP7B1) has a wide tissue distribution and high enzymatic activity, for example towards 25- and 27-hydroxycholesterol (16, 2832). The possibility has been discussed that one of the major biological roles of CYP7B1 may be to inactivate 25- and 27-hydroxycholesterol by 7{alpha}-hydroxylation (32). This conversion is likely to render them considerably less toxic.

To summarize, it is evident that the location of the additional oxygen function in an oxysterol is of critical importance for its rate of translocation between lipophilic compartments. As judged from the results of the investigation on the oxysterols studied here, there is a clear relation between this rate of translocation in vitro and the kinetic behavior of the oxysterol in vivo. There is also a relation between this translocation and the ability of an oxysterol to suppress cholesterol synthesis.


    ACKNOWLEDGMENTS
 
The skillful technical assistance of Manfred Held is gratefully acknowledged. We are also grateful to Dr. Lars Ståhle for valuable discussions. This work has been supported by grants from the Swedish Medical Research Council (project 3141) and by the Swedish Heart Lung Foundation.

Manuscript received July 26, 2002 and in revised form September 11, 2002.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
  1. Björkhem, I., and U. Diczfalusy. 2002. Oxysterols: friends, foes, or just fellow passengers? Arteroiscler. Thromb. Vasc. Biol. 22: 734–742.[Abstract/Free Full Text]

  2. Smith, L. L., and B. H. Johnson. 1989. Biological activities of oxysterols. Free Radic. Biol. Med. 7: 285–332.[CrossRef][Medline]

  3. Schroepfer, G. J., Jr. 2000. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 80: 361–554.[Abstract/Free Full Text]

  4. Björkhem, I., U. Diczfalusy, and D. Lütjohann. 1999. Removal of cholesterol from extrahepatic sources by oxidative mechanisms. Curr. Opin. Lipidol. 10: 161–165.[CrossRef][Medline]

  5. Lange, Y., A. L. Molinaro, T. R. Chauncey, and T. L. Steck. 1983. On the mechanism of transfer of cholesterol between human erythrocytes and plasma. J. Biol. Chem. 258: 6920–6926.[Abstract/Free Full Text]

  6. Lange, Y., J. Ye, and F. Strebel. 1995. Movement of 25-hydroxycholesterol from the plasma membrane to the rough endoplasmic reticulum in cultured hepatoma cells. J. Lipid Res. 36: 1092–1097.[Abstract]

  7. Vila, A., W. Korytowski, and A. W. Girotti. 2001. Spontaneous intermembrane transfer of various cholesterol-derived hydroperoxide species: kinetic studies with model membranes and cells. Biochemistry. 40: 14715–14726.[CrossRef][Medline]

  8. Theunissen, J. J., R. L. Jackson, H. J. Kempen, and R. A. Demel. 1986. Membrane properties of oxysterols. Interfacial orientation, influence on membrane permeability and redistribution between membranes. Biochim. Biophys. Acta. 860: 66–74.[Medline]

  9. Bodin, K., L. Bretillon, Y. Aden, L. Bertilsson, U. Broomé, C. Einarsson, and U. Diczfalusy. 2001. Antiepileptic drugs increase plasma levels of 4ß-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. J. Biol. Chem. 276: 38685–38689.[Abstract/Free Full Text]

  10. Lehmann, J. M., S. A. Kliewer, L. B. Moore, T. A. Smith-Oliver, B. B. Oliver, J. L. Su, S. S. Sundseth, D. A. Winegar, D. E. Blanchard, T. A. Spencer, and T. M. Willson. 1997. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272: 3137–3140.[Abstract/Free Full Text]

  11. Janowski, B. A., P. J. Willy, T. R. Devi, J. R. Falck, and D. J. Mangelsdorf. 1996. An oxysterol signalling pathway mediated by the nuclear receptor LXR{alpha}. Nature. 383: 728–731.[CrossRef][Medline]

  12. Fu, X., J. G. Menke, Y. Chen, G. Zhou, K. L. MacNaul, S. D. Wright, C. P. Sparrow, and E. G. Lund. 2001. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276: 38378–38387.[Abstract/Free Full Text]

  13. Björkhem, I. 1969. On the mechanism of the enzymatic conversion of cholest-5-ene-3-ß,7-{alpha}-diol into 7{alpha}-hydroxycholest-4-en-3-one. Eur. J. Biochem. 8: 337–344.[Medline]

  14. Bodin, K., U. Andersson, E. Rystedt, E. Ellis, M. Norlin, I. Pikuleva, G. Eggertsen, I. Björkhem, and U. Diczfalusy. 2002. Metabolism of 4ß-hydroxycholesterol in humans. J. Biol. Chem. 277: 31534–31540.[Abstract/Free Full Text]

  15. Björkhem, I., U. Andersson, E. Ellis, G. Alvelius, L. Ellegard, U. Diczfalusy, J. Sjövall, and C. Einarsson. 2001. From brain to bile. Evidence that conjugation and {omega}-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. J. Biol. Chem. 276: 37004–37010.[Abstract/Free Full Text]

  16. Björkhem, I., B. Nyberg, and K. Einarsson. 1992. 7{alpha}-hydroxylation of 27-hydroxycholesterol in human liver microsomes. Biochim. Biophys. Acta. 1128: 73–76.[Medline]

  17. Björkhem, I., D. Lütjohann, U. Diczfalusy, L. Ståhle, G. Ahlborg, and J. Wahren. 1998. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39: 1594–1600.[Abstract/Free Full Text]

  18. Breuer, O., and I. Björkhem. 1990. Simultaneous quantification of several cholesterol autoxidation and monohydroxylation products by isotope-dilution mass spectrometry. Steroids. 55: 185–192.[CrossRef][Medline]

  19. Dzeletovic, S., O. Breuer, E. Lund, and U. Diczfalusy. 1995. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225: 73–80.[CrossRef][Medline]

  20. Phillips, J. E., W. V. Rodrigueza, and W. J. Johnson. 1998. Basis for rapid efflux of biosynthetic desmosterol from cells. J. Lipid Res. 39: 2459–2470.[Abstract/Free Full Text]

  21. Steck, T. L., F. J. Kezdy, and Y. Lange. 1988. An activation-collision mechanism for cholesterol transfer between membranes. J. Biol. Chem. 263: 13023–13031.[Abstract/Free Full Text]

  22. Meaney, S., M. Hassan, A. Sakinis, D. Lütjohann, K. von Bergmann, Å. Wennmalm, U. Diczfalusy, and I. Björkhem. 2001. Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol: a stable isotope study. J. Lipid Res. 42: 70–78.[Abstract/Free Full Text]

  23. Ohvo-Rekila, H., B. Ramstedt, P. Leppimaki, and J. P. Slotte. 2002. Cholesterol interactions with phospholipids in membranes. Prog. Lipid Res. 41: 66–97.[CrossRef][Medline]

  24. Smondyrev, A. M., and M. L. Berkowitz. 2001. Effects of oxygenated sterol on phospholipid bilayer properties: a molecular dynamics simulation. Chem. Phys. Lipids. 112: 31–39.[CrossRef][Medline]

  25. Kauffman, J. M., P. W. Westerman, and M. C. Carey. 2000. Fluorocholesterols, in contrast to hydroxycholesterols, exhibit interfacial properties similar to cholesterol. J. Lipid Res. 41: 991–1003.[Abstract/Free Full Text]

  26. Babiker, A., and U. Diczfalusy. 1998. Transport of side-chain oxidized oxysterols in the human circulation. Biochim. Biophys. Acta. 1392: 333–339.[Medline]

  27. Kandutsch, A. A., and H. W. Chen. 1978. Inhibition of cholesterol synthesis by oxygenated sterols. Lipids. 13: 704–707.[Medline]

  28. Toll, A., K. Wikvall, E. Sudjana-Sugiaman, K. H. Kondo, and I. Björkhem. 1994. 7{alpha} hydroxylation of 25-hydroxycholesterol in liver microsomes. Evidence that the enzyme involved is different from cholesterol 7{alpha}-hydroxylase. Eur. J. Biochem. 224: 309–316.[Medline]

  29. Rose, K. A., G. Stapleton, K. Dott, M. P. Kieny, R. Best, M. Schwarz, D. W. Russell, I. Björkhem, J. Seckl, and R. Lathe. 1997. Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7{alpha}-hydroxy dehydroepiandrosterone and 7{alpha}-hydroxy pregnenolone. Proc. Natl. Acad. Sci. USA. 94: 4925–4930.[Abstract/Free Full Text]

  30. Martin, K. O., K. Budai, and N. B. Javitt. 1993. Cholesterol and 27-hydroxycholesterol 7{alpha}-hydroxylation: evidence for two different enzymes. J. Lipid Res. 34: 581–588.[Abstract]

  31. Schwarz, M., E. G. Lund, R. Lathe, I. Björkhem, and D. W. Russell. 1997. Identification and characterization of a mouse oxysterol 7{alpha}-hydroxylase cDNA. J. Biol. Chem. 272: 23995–24001.[Abstract/Free Full Text]

  32. Li-Hawkins, J., E. G. Lund, A. D. Bronson, and D. W. Russell. 2000. Expression cloning of an oxysterol 7{alpha}-hydroxylase selective for 24-hydroxycholesterol. J. Biol. Chem. 275: 16543–16549.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
U. Panzenboeck, U. Andersson, M. Hansson, W. Sattler, S. Meaney, and I. Bjorkhem
On the mechanism of cerebral accumulation of cholestanol in patients with cerebrotendinous xanthomatosis
J. Lipid Res., May 1, 2007; 48(5): 1167 - 1174.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Radhakrishnan, Y. Ikeda, H. J. Kwon, M. S. Brown, and J. L. Goldstein
From the Cover: Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Oxysterols block transport by binding to Insig
PNAS, April 17, 2007; 104(16): 6511 - 6518.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. S. Kim, A. S. Rahmanto, A. Kamili, K.-A. Rye, G. J. Guillemin, I. C. Gelissen, W. Jessup, A. F. Hill, and B. Garner
Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-beta Peptide Generation
J. Biol. Chem., February 2, 2007; 282(5): 2851 - 2861.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Ohyama, S. Meaney, M. Heverin, L. Ekstrom, A. Brafman, M. Shafir, U. Andersson, M. Olin, G. Eggertsen, U. Diczfalusy, et al.
Studies on the Transcriptional Regulation of Cholesterol 24-Hydroxylase (CYP46A1): MARKED INSENSITIVITY TOWARD DIFFERENT REGULATORY AXES
J. Biol. Chem., February 17, 2006; 281(7): 3810 - 3820.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Heverin, S. Meaney, D. Lutjohann, U. Diczfalusy, J. Wahren, and I. Bjorkhem
Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain
J. Lipid Res., May 1, 2005; 46(5): 1047 - 1052.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Bjorkhem and S. Meaney
Brain Cholesterol: Long Secret Life Behind a Barrier
Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 806 - 815.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
E. G. Lund, C. Xie, T. Kotti, S. D. Turley, J. M. Dietschy, and D. W. Russell
Knockout of the Cholesterol 24-Hydroxylase Gene in Mice Reveals a Brain-specific Mechanism of Cholesterol Turnover
J. Biol. Chem., June 13, 2003; 278(25): 22980 - 22988.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M200293-JLR200v1
43/12/2130    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meaney, S.
Right arrow Articles by Björkhem, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meaney, S.
Right arrow Articles by Björkhem, I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today